UK-based medical devices company Smith & Nephew has commenced operationsof BSN Medical, its joint 50:50 venture with Germany's Beiersdorf, which combines both parent companies' traditional wound care, casting, bandaging and phlebology businesses.
S&N also announced the completion of the acquisition of Beiersdorf's advanced wound care business for L30 million ($42.5 million). Both transactions were announced last year (Marketletter November 13, 2000), and it is anticipated that they will be completed this month.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze